Aurobindo Pharma has got final approval from the US health regulator for manufacturing and marketing generic version of blood pressure treatment drugs Amlodipine and Valsartan tablets.

The company has said in a BSE filing that the approval by the US Food and Drug Administration (USFDA) is for multiple strengths of 5mg/160mg, 5mg/320mg and 10mg/320 mg.

It further said that this product has been expected to be launched in the first quarter of 2016-17.

Read EquityPandit’s Technical Analysis on Nifty Pharma